Exousia Bio LMMY Ratios (2022-2026)

OTC LMMY
$0.02 +0.00 (+26.67%)
At close: Sep 2, 2026 · 4:00 PM EDT
Reported Financials

Exousia Bio Quarterly Ratios

Periods 14 quarters
Latest Feb 2026

Exousia Bio ratios data for the quarter ended Feb 2026. These financial ratios cover 14 quarters of results from May 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.

Ratios May2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Profitability
Gross Margin 100.00%100.00%-157.79%100.00%
EBT Margin -92.21%-124.39%-140.08%-104.29%
EBIT Margin -192.21%-224.39%-151.71%-115.79%
EBITDA Margin -192.21%-224.39%-151.71%-17.76%
Operating Margin -192.21%-224.39%-151.71%-115.79%
Net Margin -92.21%-124.39%-140.08%-104.29%
FCF Margin -43.97%-36.52%-37.71%-64.45%
Efficiency
Assets AverageAssets Avg. 0.04M0.03M0.03M0.03M0.03M0.03M0.03M22.05M
Asset Utilization RatioAsset Util. 0.140.290.420.550.43
Leverage & Solvency
Interest Coverage RatioInterest Cover -3.07
Debt Ratio 0.540.780.781.081.081.081.061.04
Times Interest Earned -3.07
Valuation
Price to EarningsP/E 49.50436.75-33.29-73.34-597.39-289.91
Price to BookP/B 159.580.00M-66.070.520.25
Enterprise Value 3.97M35.00M1.56M2.33M11.40M5.53M
EV to EBIT 568.000.01M-54.65-73.34-48.10-23.34
EV to EBITDA 568.000.01M-54.65-73.34-48.10-23.34
Market Capitalization 3.97M35.00M1.56M2.33M11.40M5.53M
Price to FCFP/FCF 44.59-17.08666.6066.10
EV to FCF 44.58-17.08666.6066.10
EV to CFO 43.95-17.08666.6065.85
Return Ratios
Return on Sales [ROS]ROS -0.01%-0.01%-0.01%-0.01%0.06%0.20%0.29%
Return on Capital Employed [ROCE]ROCE -168.79%-200.09%-265.65%-323.56%-260.91%-248.41%-2.45%
Return on Assets [ROA]ROA -0.02%-0.02%-0.02%-0.02%-0.01%-0.01%0.03%0.00%